ArticleKidney international reports2023

Randomized Trial Comparing SGLT2 Inhibition and Hydrochlorothiazide on Sympathetic Traffic in Type 2 Diabetes.

Karsten Heusser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.